Home/Senseonics/Francine R. Kaufman, M.D.
FR

Francine R. Kaufman, M.D.

Chief Medical Officer

Senseonics

Therapeutic Areas

Senseonics Pipeline

DrugIndicationPhase
Eversense E3 / XL (180-day)Continuous Glucose Monitoring for DiabetesFDA PMA Approved
Eversense 365-day SystemContinuous Glucose Monitoring for DiabetesCE Mark Approved
Next-Generation CGM SystemContinuous Glucose Monitoring for DiabetesResearch & Development